Puretech founded entity akili collaborates with weill cornell medicine, newyork-presbyterian hospital and vanderbilt university medical center to study digital therapeutic akl-t01 as potential treatment for patients with covid brain fog

Boston--(business wire)--puretech health plc (nasdaq: prtc, lse: prtc) (“puretech” or the “company”), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, is pleased to note that its founded entity, akili interactive (akili) today announced collaborations with weill cornell medicine, newyork-presbyterian hospital and vanderbilt university medical center to evaluate akili digital therapeutic ak
PRTC Ratings Summary
PRTC Quant Ranking